Genetic Vaccination for the Immunotherapy of B-Cell Malignancies

By  

Current Gene Therapy, Vol. 2, Iss. 2, 2002-01 ,pp. : 235-242

Bentham Science Publishers

Access to resources Recommend Favorite

Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies

By Bornstein Gadi   Quéva Christophe   Tabrizi Mohammad   Abbema Anne   Chavez Carlos   Wang Ping   Foord Orit   Ahluwalia Kiran   Laing Naomi   Raja Sandhya   Wen Shenghua   Green Larry   Yang Xiaodong   Webster Carl   Stewart Ross   Blakey David  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 561-574

Springer Publishing Company

Access to resources Recommend Favorite

Stem Cell Transplant and Idiotypic Vaccination for B-Cell Malignancies

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 13, 2011-07 ,pp. : 1653-1660

Bentham Science Publishers

Access to resources Recommend Favorite

Human monoclonal antibodies to immunoglobulin superfamily receptor translocation- associated-3, -4 and -5 molecules as potential therapeutic agents for B-cell malignancies

By  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 11, 2006-11 ,pp. : 1593-1600

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies

By Korycka-Wołowiec Anna   Robak Tadeusz  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1455-1468

Informa Healthcare

Access to resources Recommend Favorite